The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

[3] Mounjaro: One of Lilly's name-brand tirzepatide medications. Mounjaro is FDA-approved for type 2 diabetes. [4] Compounded ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type ...

Brand-heavy companies ... While some drug patents are due to expire in the next couple of years, analysts expect generic anti-obesity and anti-diabetic GLP-1 drugs to be the major catalyst for ...

Ozempic, a drug initially used to treat type 2 diabetes, is gaining attention for its weight loss benefits and potential to reduce Alzheimer's risk. However, it comes with side effects like nausea, ...

The tracker allows patients to self-identify, provide their location, and say which brand of GLP-1 drug they ... the key ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...